Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder

NCT02461927 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02461927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02461927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine for The Rapid Treatment of Major Depression and Alcohol Use Disorder
Lead sponsor
VA Office of Research and Development
Phase
Phase 1/2
Overall status
Completed
Start date
January 1, 2015
Completion date
October 30, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, major depressive disorder